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ARE PEOPLE FOLLOWING HIP AND KNEE ARTHROPLASTY AT 
GREATER RISK OF EXPERIENCING A FALL AND FRACTURE? DATA 
FROM THE OSTEOARTHRITIS INITIATIVE 
 
 
ABSTRACT 
 
Introduction Falls are a major challenge for older people and are a significant source of mortality and 
morbidity. There has been uncertainty as to whether people with total hip (THA) or knee (TKA) 
arthroplasty have a greater risk of falls and associated fractures. This analysis was to explore this question 
with a large community dataset. 
 
Materials and Methods:  Data from all people enrolled onto the US Osteoarthritis Initiative programme 
who had undergone a THA (n=104) or TKA (n=165), within a 12 month period, were compared to those 
who had not undergone an arthroplasty (n=4631). Data was collected on: the number of participants who 
reported a fall within a 12 month period; the frequency of falls in this period; and whether a fracture was 
sustained during this period. Odd ratios were calculated for the probability of experiencing a fall or 
fracture between the groups.  
 
Results: There was no statistical difference in falls between people following THA (OR 0.90; 95% CI: 
0.58 to 1.41) or TKA (OR: 0.95; 0.67 to 1.35) compared to a non-arthroplasty cohort. Whilst there was 
no statistical difference in fracture risk between people following TKA compared to non-arthroplasty 
individuals (OR: 1.25; 95% CI: 0.57 to 2.70), those who underwent THA had a 65% lower chance of 
experiencing a fracture in the initial 12 post-operative months compared to the non-THA cohort (OR 
0.35; 95% CI: 0.19 to 0.65; p<0.01).  
 
Conclusions: There appears a lower chance of experiencing a fracture for people following THA 
compared to those who have not. 
 
Keywords: lower limb; joint replacement; osteoarthritis; community-dwelling; trauma; rehabilitation 
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INTRODUCTION 
 
 
Falls and their subsequent injuries are a major cause of morbidity and mortality in older people [1]. It 
has been estimated that the prevalence of falls in people aged 65 years and over is 30% in community-
dwelling individuals, and in 50% of those aged 85 year and older [2]. Falls related injuries can range 
from minimal soft tissue injury to more serious life and limb threatening injuries such as fractures, head 
injuries and chest or abdominal contusion [3].  
 
Hip and knee arthroplasty are two of the most common orthopaedic procedures worldwide and are the 
treatment of choice for end-stage symptomatic osteoarthritis [4]. The number of people undergoing 
primary total hip (THA) and knee (TKA) arthroplasty is expected to increase in number from 95,877 to 
118,666 by 2035 [5]. The mean age for such procedures ranges from 68 to 70 years. Both pre- and early 
post-operatively, such people may have reduced muscle strength, endurance, balance and joint range of 
motion as a consequence of their degenerative or recovering arthroplasty joint, in addition to other 
symptomatic degenerative joints which present in a high proportion of the osteoarthritis population [6,7]. 
Previous cohorts have demonstrated that people with hip or knee osteoarthritis, the most frequent 
indication for TKA or THA [4], have greater falls and fracture risk compared to the general (non-
osteoarthritis) population [8,9]. Therefore these are major physical risk factors attributed to increase risks 
of experiencing a fall [10]. 
 
Previously it has been unclear whether patients who have undergone THA or TKA are at higher risk of 
falling. Matsumoto et al [11] reported that in their age- and gender-matched cohort of 81 patients, who 
underwent TKA, the incidence of falls was 38% in the first year post-operatively, compared to 24% in 
non-TKA cohort. These results were lower than previous cohorts of 43% [12], but similar to Ikuotomo 
et al’s [13] THA cohort of 36%, and higher than that reported by Swinkels and Allain [14] and Swinkels 
et al [15] at 23% and 24% respectively. Furthermore, previous cohorts have demonstrated a higher risk 
of hip fracture in people who undergo a TKA in the first 12 months, reported at 54% and 57% increased 
risk of hip fracture in Lalmohamed et al [16] and Prieto-Alhambra et al [17] respectively. In contrast, 
previous literature has demonstrated a significant improvement in gait and balance in those who have 
undergone THA and TKA to address these key physical risk factors to falling [18-20]. 
 
However, it remains unclear whether there is a difference in falls rates and subsequent fractures for 
people who undergo THA or TKA based on a large cohort of individuals. It also remains uncertain 
whether specific subgroups within the arthroplasty population are at particular risk of falls and falls-
related fracture. Therefore, examining the difference between sufficiently powerful matched cohorts of 
non-arthroplasty older people, to the arthroplasty population over an initial 12 months post-operatively 
would be valuable. Through this, it will be possible to determine firstly whether people following THA 
and TKA are at lesser or greater risk of falls post-operatively; secondly, whether this risk changes in the 
initial post-operative period; and thirdly whether certain individuals are at greater risk than others. This 
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will be valuable as it may lead to a more strategic approach to rehabilitating people post-arthroplasty, 
thereby improving the recovery of this population which is growing in number. Accordingly the purpose 
of this analysis was to explore the risk factors associated with falls and subsequent fracture for those 
people with and without THA or TKA. 
 
 
MATERIALS AND METHODS 
 
 
Data used in the preparation of this article were obtained from the Osteoarthritis Initiative (OAI) 
database, which is available for public access at http://www.oai.ucsf.edu/. The OAI is a large-scale, 
multi-centre (four sites across the USA), longitudinal cohort study aimed to investigate the role of 
biomarkers in the development and progression of lower limb osteoarthritis.  
 
Baseline data were collected between February 2004 to May 2006, and then longitudinally collected at 
12, 24, 30, 36, 48, 60, 72 and 84 months follow-up intervals. Data collected included: individual's 
demographic characteristics, previous and current medical history including medical morbidities, 
lifestyle and physical activity assessed using the Physical Activity Scale for the Elderly (PASE) [21]. 
This is a 12-question tool which evaluates the frequency and duration of leisure activity (e.g., sports, 
jogging, swimming, strengthening and endurance exercise), household activity and work-related activity 
during a previous seven-day period. For this analysis we collated data on: the number of participants who 
reported a fall within a 12 month period; the frequency of falls in this period; whether a fracture was 
sustained during this period; and the type of fracture (when recorded).  
 
The whole OAI cohort was included in this analysis. Specifically, to answer this research question, we 
identified all individuals who had had a THA or TKA within the first 12 post-operative months, and 
compared outcomes to those who had not undergone an arthroplasty. Through this it was possible to 
attribute the outcomes of these individuals within the first 12 months of received a THA or TKA.  
 
Data analysis 
 
Descriptive statistics were initially used to analyse the trends and patterns in categorical and continuous 
data. The normality of the dataset was analysed using the Shapiro-Wilks test. 
 
The aim of the analysis was to determine whether there was a difference in incidence of falls, with or 
without a consequential fracture, between people who had undergone a THA or TKA within their first 
12 post-operative months, compared to those who had not. To determine this we compared the 
arthroplasty groups to non-arthroplasty groups using a Mann-Whitney U Test to assess mean cumulative 
falls, and a chi-square test to assess the occurrence of a fall and the occurrence of a fracture within the 
first 12 post-operative months. 
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Secondly, we aimed to determine what factors may be associated with the occurrence of a fall and/or 
fracture within people who had undergone a THA or TKA within the first 12 post-operative months. To 
determine this, a univariate analysis was initially undertaken with the dependent variables: occurrence 
of a fall and occurrence of a fracture within the study period. The independent variables identified 
through previous research as potential explanatory factors included: age, gender, ethnicity, marital status, 
employment status, previous THA (in the TKA cohort), previous TKA (in the THA cohort), diagnosis 
of hip osteoarthritis, diagnosis of knee osteoarthritis, and use of bisphosphonates in past 12 months. 
Based on these, all variables identified as significant at p<0.01 on univariate analysis were entered into 
a multivariate logistical regression model. All logistical regression data was expressed as odd ratios (OR) 
with 95% confidence intervals (CI) and p-values. Statistical significance was denoted at p>0.05 on 
multivariate analysis and OR interpretation. The Wald statistic was used to assess statistical significance 
in each regression model. All analyses were undertaken using STATA version 12.0 (STATACorp LP, 
Texas, USA). 
 
Ethics approval 
The OAI programme’s ethical approval was granted by the Committee on Human Research, University 
of California, San Francisco (IRB approval number 10-00532: Approved 10th March 2015).  
 
RESULTS 
 
 
A study flow chart is presented as Figure 1. In total, data on falls and participant characteristics was 
available for 104 people who had undergone THA and 165 who had undergone TKA. Consequently, it 
was possible to compare the THA cohort to 4692 non-THA participants and 4631 individuals to the TKA 
cohort. The demographic characteristics of the cohorts are presented in Table 1. As this demonstrates, 
the characteristics of each comparable group were broadly similar; the exceptions being for the THA 
cohort, where the mean age of the THA cohort was four years older. There was a slightly higher 
proportion of people diagnosed with concomitant knee osteoarthritis in the THA cohort (15%) compared 
to the non-THA cohort (10%), and the non-THA group had a higher PASE score (mean=151) compared 
to the THA group (mean=142). In the TKA analysis, the groups were largely similar; with the exception 
being that the TKA group demonstrated a slightly greater proportion of people with concomitant hip 
osteoarthritis (9%), compared to the non-TKA group (4%). The proportion of people prescribed 
bisphosphonates was broadly similar throughout the four groups (Table 1).  
 
 
Total Hip Arthroplasty 
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There was no statistically significant difference between the chances of experiencing a fall in the initial 
12 months post-THA compared to non-THA cohort from the dataset (Table 2). The chances of 
experiencing a fall was 10% less in the THA cohort compared to the non-THA cohort in the 12 months 
assessed (OR 0.90; 95% CI: 0.58 to 1.41). However this did not reach statistical significance (p=0.66). 
There was no significant difference between the two groups for mean cumulative falls in the 12 months 
assessed (mean: 0.57 versus 0.49; p=0.27).  However, there was a difference in fracture risk. Those who 
underwent a THA had a 65% lower chance of experiencing a fracture in the initial 12 postoperative 
months compared to the non-THA cohort (OR 0.35; 95% CI: 0.19 to 0.65; p<0.01).  
 
The results of the univariate analysis are illustrated in Table 3. This demonstrates that age (OR 0.99; 95% 
CI: 0.98 to 1.00), gender (OR 1.28; 95% CI: 1.03 to 1.58), bisphosphonate use (OR 1.23; 95% CI: 1.03 
to 1.58), having not undergone a previous TKA (OR 0.35; 95% CI: 1.04 to 1.20) and a physician-
diagnosis of knee osteoarthritis (OR 1.51; 95% CI: 1.06 to 2.14) were potentially significant predictors 
of falls in the initial 12 post-operative THA months. However, on multivariate analysis only having not 
undergone a previous TKA was identified as a statistically significant predictor, reducing the chances of 
experiencing a fall in the initial 12 post-THA months by 85% (OR 0.15; 95% CI: 0.04 to 0.53; 
Supplementary File 1). 
 
Only bisphosphonate use was identified as a significant predictor of fracture in the past 12 months from 
the THA cohort, where people who took bisphosphonates were at a nearly two and a half times greater 
chance of experiencing a fracture within the first 12 months post-THA (OR 2.41; 95% CI: 1.59 to 3.67; 
Table 3). 
 
Total Knee Arthroplasty 
 
There was no statistically significant difference in the chances of someone experiencing a fall or fracture 
following TKA compared to the non-TKA cohort (Table 2). The chances of experiencing a fall in the 
first 12 months post-TKA was 5% lower than in the non-TKA cohort (OR: 0.95; 0.67 to 1.35; p=0.77). 
However, whilst there was a 25% greater chance of experiencing a fracture in the TKA cohort compared 
to non-TKA cohort in the initial 12 months post-TKA (OR: 1.25; 95% CI: 0.57 to 2.70), this was not a 
statistically significant relationship. The cumulative number of falls experienced in the assessed 12 
month period was not statistically significantly different between the TKA and non-TKA cohorts (mean: 
0.40 falls versus 0.48 falls; p=0.99). 
 
Table 3 illustrates the univariate analysis results from the TKA cohort. This demonstrated that predictors 
such as gender (OR 0.86; 95% CI: 0.76 to 1.00), bisphosphonate use (OR 1.23; 95% CI: 1.03 to 1.58) 
and a physician-diagnosis of hip osteoarthritis (OR 1.34; 95% CI: 0.93 to 0.94) were significant 
predictors of experiencing a fall within the 12 month assessment period. However, only bisphosphonate 
use remained a significant predictor on multivariate analysis (OR 1.25; 95% CI: 1.00 to 1.56; 
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Supplementary Table 1), where those who took bisphosphonates demonstrated a 25% greater chance of 
experiencing a fall in the first post-operative year. 
 
Bisphosphonate use (OR 2.01; 95% CI: 01.45 to 3.37), marital status (OR 1.13; 95% CI: 0.99 to 1.30), 
current employment (OR 0.86; 95% CI: 0.56 to 1.30) and having not undergone a previous THA (OR 
0.86; 95% CI: 0.76 to 1.00) were significant predictors of experiencing a fracture within 12 months of a 
TKA on univariate analysis. However on multivariate analysis, only bisphosphonate use remained a 
significant predictor, where people following TKA who took bisphosphonates were over twice as likely 
to have a fracture within 12 months post-operative, compared to those who did not (OR 2.24; 95% C I: 
1.45 to 3.49; Supplementary Table 1). 
 
 
DISCUSSION 
 
 
There was no direct evidence supporting the hypothesis that people who undergo TKA are at any greater 
or lesser risk of falls or fractures during their first 12 post-operative months. Whilst there was no direct 
evidence that people who undergo TKA are at any different risk of experiencing a fall in their first 12 
post-operative months, THA did confer a reduced risk of fracture in this period, with a 65% lower chance 
of experiencing a fracture following THR, compared to non-arthroplasty cohort. Bisphosphonate 
prescription was identified as a significant predictor of fracture and falls risk for people following THA 
or TKA, however it remains unclear whether this is a cause or consequence of such adverse events within 
the assessing 12 month intervals. Having undergone TKA was also identified as a significant predictor 
of reducing the chances of experiencing a fall in the initial 12 months post-THA. 
 
Ikutomo et al [13] previously reported an increased occurrence of falls in the initial 12 months after TKA; 
however these analyses had not compared falls in THA and TKA against a similar non-arthroplasty 
cohort. Matsumoto et al (2014) did compare their findings to age and gender matched cohorts, reporting 
a significantly higher incidence of falls in people post-arthroplasty (p=0.04). However they did not 
control for the duration since operation, which has been identified as a significant predictor of falls [13]. 
Nonetheless, both the current data and previous literature has emphasised that the prevalence of falls is 
considerable in this population, being estimated in up to 48% of patients in the first post-operative year 
[22]. This reiterates that both the arthroplasty and non-arthroplasty populations in general should be 
considered populations that would potentially benefit from falls rehabilitation if this is indicated in 
specific individuals with a history of this adverse event.  
 
Age and gender were reported as predictors of falls or fracture in the univariate analyses. Previously 
Lalmohamed et al [16] reported an association between TKA and increased hip fracture; however, this 
was not reproduced in this cohort, with contrary findings reported in this dataset. This may be attributed 
to the difference in ages where the mean age of the TKA cohort in our dataset was 68 years, compared 
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to the increased age reported in Lalmohamed et al’s [16] cohort who were ages 70 years and older. The 
findings of similar fracture rates between THA and TKA cohorts and age and gender matched cohorts 
reported in Prieto-Alhambra et al [17,23] but only at three year follow-up, though similar data from the 
UK General Practice Research Dataset reported by the same team concluded that risk was greater in the 
THA cohort up to five years post-operatively. These results may be attributed to lower age group in our 
analysis, or the non-significant findings may be related to the smaller individuals samples and type II 
statistical error, which our THA and TKA cohorts may have represented compared to Prieto-Alhambra 
et al’s [17,23] 14,133 THA and 20,033 TKAs.  
 
Only the prescription of bisphosphonates was identified as a consistent predictor of falls or fracture risk 
in this analysis in the multivariate analyses, although this should be interpreted with caution. Given the 
longitudinal, annual assessment approach adopted by the OAI programme, it was not possible to 
distinguish whether bisphosphonate use commenced before or after falls and fracture events occurred. 
Given that it is recommended national and international guidance that people at risk of falls with 
subsequent insufficiency fractures should be routinely prescribed some form of bisphosphonate [24,25], 
it would appear a sensible hypothesis that the analysed falls and fracture population were prescribed 
these medications following their initial fall. Thus, this finding is measurement artefact rather than 
indicating a causal relationship between bisphosphonate use and fracture and falls. This is supported by 
the literature which has not reported such a previous association [24], whilst also emphasising that these 
medications are indicated for people at risk of fractures related to falls to mitigate this potentially fatal 
event [26]. The findings that there is a relationship between falls, fracture and bisphosphonates is 
therefore an encouraging finding, as it suggests that those who are at most need of such pharmacological 
agents, are prescribed these medications. 
 
The findings of this study suggest that there is little difference in fracture or falls risk between those who 
have and those who have not undergone THA or TKA. Given that people following joint arthroplasty 
pre-operatively have greater pain, loss of joint range of motion and increased disability, which has been 
shown to increase falls risk [27,28], joint arthroplasty and the subsequent rehabilitation and recovery 
undertaken by this population, may mitigate these previously reported trends. The results therefore 
suggest that in respect to falls, the current rehabilitation provided to cohorts such as the US OAI dataset 
is sufficient and further falls management strategies should therefore only be routinely employed for 
those exceptional cases who are at greatest risk. The minimal difference in falls and fracture risk between 
people who have undergone a THA and TKA is notable from this dataset. Whilst a good recovery 
following THR has been widely considered to be high in this population [29], between 20% to 30% of 
people following TKA still present with residual pain, loss of motion and functional difficulties at 12 
and 24 post-operative months [30,31]. Since these are all recognised risk factors to falls, the minimal 
difference between the cohorts is an interesting finding which may or may not be representable of the 
wider population.  
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This analysis presented with five notable limitations. Firstly, the OAI dataset did not collect information 
related to the type of falls and possible contributing factors to falls. Therefore it remains unclear whether 
the falls experienced between people following THA or TKA were in relation to physical activity and 
being more physically active or to more sedentary activities. This would be valuable as it could help 
identify where best to support this population to reduce future falls risk. Secondly, the OAI dataset 
reported falls and fracture events which occurred in a 12 months period. It was not possible to distinguish 
between the number and type of falls which occurred within the initial post-operative period (i.e. six to 
12 weeks post-surgery) compared to the remaining follow-up period. Given that previous literature has 
suggested that rehabilitation and recovery may take up to six months for people following THA or TKA 
[32,33], it would have been valuable to have analysed by recovery period, to explore the potential 
importance of this. Thirdly, there was limited data available through the dataset on the location and type 
of fracture experienced by the cohort; this was due to a high number of missing data-points. Such an 
analysis would have provided an indication as to whether the types of fractures experienced by the cohort 
differed, and may be a useful addition for future research on this post-surgical population.  Fourthly, we 
included data from all potentially eligible individuals rather than basing the sample size on an a priori 
power calculation. The number was therefore self-determined by the size of the OAI dataset. Finally, the 
OAI database is a cohort of individuals from North America who have volunteered to a research project. 
Whilst this provides valuable data, this cohort may be considered a self-selecting sample of healthier and 
more educated or affluent individuals compared to the full spectrum of clinical practice, and may 
therefore limit generalisability to the wider population from different economic, social and cultural 
backgrounds worldwide. 
 
 
CONCLUSIONS 
 
Whilst people following TKA or THA have no greater risk of falls or fracture events in the initial 12 
post-operative months compared to people who have not undergone THA or TKA, there appears a lower 
chance of experiencing a fracture for people following THA compared to those who have not.  
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FIGURE AND TABLE LEGENDS 
 
 
Figure 1: Flow-chart illustrating the subject selection based on a priori eligibility criteria. 
 
Table 1: Demographic characteristics 
 
Table 2: Difference between arthroplasty and non-arthroplasty groups for falls and fracture outcomes 
over 12 month follow-up 
 
Table 3: Univariate analysis: factors associated with falls and fractures in people who have undergone 
THA or TKA during the first 12 post-operative months (OR and 95% CI: p-value) 
 
Supplementary File 1: Multivariate analysis with probability values and odd ratio; 95% confidence 
intervals (when statistically significant) for predicting falls or fractures in people who have undergone 
THA or TKA during the first 12 post-operative months, when indicated as significant on univariate 
analysis. 
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Figure 1: Flow-chart illustrating the subject selection based on a priori eligibility 
criteria. 
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Table 1: Demographic characteristics 
 
 Non-THA  THA Non-TKA  TKA 
N 4692 104 4631 165 
Gender (m/f; %) 1949/2743  
(41.5/ 58.5) 
43/61  
(41.3/58.7) 
1923/2708  
(41.5/58.5) 
69/96 
(41.8/58.2) 
Mean Age in years (SD) 66.8 (9.0) 71.1 (9.2) 66.9 (9.0) 67.6 (9.1) 
Race (n; %) 
1: Other non-white 
2: White or Caucasian 
3: Black or African American 
4: Asian 
 
1: 81 (1.7) 
2: 3704 (79.0) 
3: 859 (18.3) 
4: 43 (1.0) 
 
1: 1 (1.0) 
2: 86 (82.7)  
3: 15 (14.4)  
4: 2 (1.9)  
 
1: 81 (1.8)  
2: 3651 (78.9) 
3: 850 (18.4)  
4: 44 (0.9) 
 
1: 0 (0.0) 
2: 139 (84.8) 
3: 24 (14.5) 
4: 1 (0.7) 
Marital Status (n; %) 
1: Married 
2: Widowed 
3: Divorced 
4: Separated 
5: Never married 
 
1: 3252 (71.9) 
2: 411 (9.1) 
3: 498 (11.0) 
4: 47 (1.0) 
5: 317 (7.0) 
 
1: 60 (67.4) 
2: 8 (9.0) 
3: 9 (10.1) 
4: 0 (0.0) 
5: 12 (13.5) 
 
1: 2325 (64.8) 
2: 404 (11.3) 
3: 493 (13.7) 
4: 45 (1.3) 
5: 319 (8.9) 
 
1: 87 (68.0) 
2: 15 (11.7) 
3: 14 (10.9) 
4: 2 (1.6) 
5: 10 (7.8) 
Employed (y; %) 2247 (47.9) 45 (43.3) 2209 (47.7) 81 (49.1) 
Number of THA (y; %) 0 (0.0) 104 (100.0) 17 (0.4) 2 (1.2) 
Number of TKA (y; %) 25 (0.5) 2 (1.9) 0 (0.0) 165 (100.0) 
Number of hip OA diagnosed (y; %) 135 (2.9) 42 (40.4) 163 (3.5) 14 (8.5) 
Number of knee OA diagnosed (y; %) 441 (9.5) 15 (14.4) 471 (10.2) 67 (40.6) 
Bisphosphonates prescribed (y; %) 592 (12.6) 16 (15.4) 608 (13.1) 31 (18.8) 
Mean PASE score (SD) 151.1 (82.5) 141.5 (80.9) 146.3 (82.7) 149.2 (75.4) 
Type of bisphosphonate prescribed (n; 
%) 
0: None 
1: Alendronate 
2: Risedronate 
3: Alendronate and Risedronate 
4: Other 
 
 
0: 3779 (86.5) 
1: 419 (9.6) 
2: 113 (2.6) 
3: 49 (1.1) 
4: 10 (0.2) 
 
 
0: 90 (86.5) 
1: 11 (10.6) 
2: 2 (1.9) 
3: 1 (1.0) 
4: 0 (0.0) 
 
 
0: 3877 (86.5) 
1: 431 (9.6) 
2: 114 (2.5) 
3: 49 (1.1) 
4: 9 (0.3) 
 
 
0: 134 (81.2) 
1: 22 (13.4) 
2: 7 (4.2) 
3: 2 (1.2) 
4: 0 (0.0) 
 
f – female; m – male; N – number; OA – osteoarthritis; PASE – Physical Activity Scale for the Elderly; 
SD – standard deviation; THA – total hip arthroplasty; TKA – total knee arthroplasty; Y - Yes 
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Table 2: Difference between arthroplasty and non-arthroplasty groups for falls and 
fracture outcomes over 12 month follow-up 
 
 Arthroplasty 
Group 
 
Non-Arthroplasty  
Group 
Odd Ratio (95% CI) 
THA 104 4692  
Fall in past 12 months (Y; %) 26 (25.0) 1265 (27.0) 0.90 (0.58 to 1.41; 0.66) 
Fracture in the past 12 months (Y;%) 146 (13.5) 12 (0.9) 0.35 (0.19 to 0.65; <0.001)  
Mean Cumulative falls in past 12 months (SD) 0.57 (0.86) 0.49 (0.85) P=0.27 (-0.10 to 0.26)* 
TKA 165 4631  
Fall in past 12 months (Y; %) 43 (26.1) 1254 (27.1) 0.95 (0.67 to 1.35; 0.77) 
Fracture in past 12 months (Y; %) 7 (4.2) 159 (3.4) 1.25 (0.57 to 2.70; 0.58) 
Mean Cumulative falls in past 12 months (SD) 0.40 (0.78) 0.48 (0.84) P=0.99 (-2.48 to 2.64)* 
 
* Student-t test (95% CI); CI – confidence intervals; OA – osteoarthritis; SD – standard deviation; 
THA – total hip arthroplasty; TKA – total knee arthroplasty; Y - Yes
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Table 3: Univariate analysis: factors associated with falls and fractures in people who have undergone THA or TKA during the first 12 post-
operative months (OR and 95% CI: p-value) 
 
 Age Gender Bisphosphonate 
Use 
Marital 
Status 
Employment THA TKA Hip OA Knee OA Race 
THA           
Fall in past 
12 months 
0.99 (0.98, 
1.00) 0.07 
0.87 (0.74, 
1.02) 0.08 
 
1.28 (1.03, 1.58) 
0.02 
1.00 (0.94, 
1.01) 0.96 
1.07 (0.89, 
1.27) 0.48 
- 0.35 (1.04, 
1.20) 0.09 
1.00 (0.79, 
1.26) 0.24 
1.51 (1.06, 
2.14) 0.02 
0.94 (0.78, 
1.13) 0.52 
Fracture 
in past 12 
months 
1.00 (0.99, 
1.03) 0.46 
1.05 (0.72, 
1.54) 0.79 
 
2.41 (1.59, 3.67) 
<0.01 
0.98 (0.84, 
1.14) 0.75 
1.00 (0.65, 
1.52) 0.99 
- 0.00 (0.00, 
0.00) 1.00 
1.36 (0.82, 
2.25) 0.24 
1.28 (0.59, 
2.78) 0.54 
0.74 (0.46, 
1.0) 0.22 
TKA           
Fall in 
past 12 
months 
1.00 (0.99, 
1.00) 0.84 
0.89 (0.76, 
1.00) 0.15 
1.23 (1.03, 1.58) 
0.03 
1.01 (0.95, 
1.07) 0.81 
0.86 (0.56, 
1.30) 0.47 
1.62 (0.64, 
4.08) 0.31 
- 1.34 (0.93, 
1.94) 0.12 
0.96 (0.76, 
1.21) 0.72 
1.05  (0.87, 
1.27) 0.59 
Fracture 
in past 12 
months 
1.00 (0.98, 
1.02) 0.84 
0.89 (0.61, 
1.30) 0.54 
 
2.01 (1.45, 3.37) 
<0.01 
1.13 
(0.99, 
1.30) 0.08 
0.86 (0.56, 
1.30) 0.08 
3.06 (0.68, 
13.79) 0.15 
- 1.10 (0.48, 
2.55) 0.82 
1.26 (0.74, 
2.14) 0.39 
0.96 (0.62, 
1.49) 0.86 
 
CI – confidence intervals; OA – osteoarthritis; OR – odd ratio; THA – total hip arthroplasty; TKA – total knee arthroplasty  
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Supplementary File 1: Multivariate analysis with probability values and odd ratio; 95% confidence intervals (when statistically significant) for 
predicting falls or fractures in people who have undergone THA or TKA during the first 12 post-operative months, when indicated as significant 
on univariate analysis. 
 
THA cohort 
 
 Age Gender Bisphosphonate Use TKA Knee OA 
Fall in past 12 months 0.95 1.00 0.94 0.15 (0.04, 0.53) 0.003 0.91 
 
TKA cohort  
 
 Gender Bisphosphonate Use Marital Status Employment THA Hip OA 
Fall in past 12 months 0.30 1.25 (1.00, 1.56) 0.05 Not eligible Not eligible Not eligible 0.09 
Fracture in past 12 months Not eligible  2.24 (1.45, 3.49) <0.01 0.23 0.48 0.11 Not eligible 
 
 
OA – osteoarthritis; THA – total hip arthroplasty; TKA – total knee arthroplasty  
 
